Jakarta, July 17 -- The Food and Drug Monitoring Agency (BPOM) is actively monitoring the safety of Bio-TCV, Indonesia's first locally developed conjugate typhoid vaccine.

The vaccine-born from a joint effort between the University of Indonesia (UI) and state-owned pharmaceutical giant Bio Farma-is being hailed as a critical milestone in strengthening national health resilience and ending its deep reliance on imported medicine.

BPOM Head Taruna Ikrar stated here on Friday that the partnership is a strategic response to Indonesia's high burden of typhoid fever cases.

It is also part of national efforts to break the country's 94-percent dependence on imported raw materials for medicines and vaccines.

"To ensure immediate access and prot...